CREDIT: TRELLEBORG MEDICAL SOLUTIONS
Trelleborg Medical Solutions exhibits advanced solutions for medical devices and pharmaceutical and biotech applications at MD&M Minneapolis in Minneapolis, Minnesota, October 16-17, 2024, in booth 3703.
On display are products enhanced by Trelleborg’s Integrated Solutions approach which offers customers business efficiency by consolidating supply chains, reducing risk, and driving savings through bundled purchasing processes, consolidated audits, shipping and logistics.
Dale Gildemeister, product manager, Integrated Solutions, Trelleborg Medical Solutions, says: “With Integrated Solutions, our simplified supply chain makes it easier to control costs to benefit our customers. Through comprehensive, unified quality management systems, we provide consistency, efficiency and reduced risk across all manufacturing operations globally. This simplifies supplier auditing processes and ensures the highest quality standards are met to protect patient lives. When we take care of the details, customers can focus on creating innovative solutions to positively impact the lives of patients.”
Also featured are Trelleborg’s advanced capabilities in drug elution and active pharmaceutical ingredient (API) capabilities for implantable drug delivery.
Don Bonitati, Americas segment director, Trelleborg Medical Solutions, says: “We know that biodurable materials, like silicone, are uniquely capable of providing the greatest possible time extension for a therapy to be released with a single dose. However, many drug developers struggle to deliver therapies to a specific site within the body or need to overcome low bioavailability of their drugs. Implantable drug delivery addresses these challenges, and for patients it could mean less time in the doctor’s office and not having to remember to take their medication. Targeted delivery also enables lower dosages to achieve the same therapeutic effect as higher dosages delivered using traditional methods. This greatly minimizes, and potentially eliminates, negative side effects for the patient.”
Further highlights include solutions offered by Trelleborg’s Innovation Center which reduce time to market for manufacturers.
Chris Tellers, global technology director, Trelleborg Medical Solutions, says: “For healthcare and medical innovators looking to create high-performing products and measurably reduce go-to-market timelines, our team at the Innovation Center can create samples in days, enabling multiple design iterations to be tested to confirm effective production and rapid scale up. Engineers and product innovators get direct access to some of the best minds in materials science, design for manufacturability, tooling and prototyping, plus proven processes for improving critical outcomes in development and manufacturing.”
Additionally, attendees can see examples of thermoplastic injection molding, elastomer-molded and extruded tubing, hose, sheeting, multicomponent parts and micromolding offerings.
For more details about Trelleborg Medical Solutions, go to https://www.trelleborg.com/medical.